Recent developments in sweat analysis and its applications

International Journal of Analytical Chemistry

Volumn 2015, Issue , 2015, Pages

  Jadoon, Saima ^a   Karim, Sabiha ^b   Akram, Muhammad Rouf ^c   Kalsoom Khan, Abida ^d   Zia, Muhammad Abid ^e   Siddiqi, Abdul Rauf ^f   Murtaza, Ghulam ^d  

^a University of Kurdistan Hawler   (Iraq)

^b UNIVERSITY OF THE PUNJAB   (Pakistan)

^c UNIVERSITY OF SARGODHA   (Pakistan)

^d COMSATS Institute of Information Technology ^*  (Pakistan)

^e UNIVERSITY OF EDUCATION   (Pakistan)

^f NONE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; CHEMISTRY;

BIOFLUIDS; CLINICAL USE; CYSTIC FIBROSIS; ITS APPLICATIONS;

BODY FLUIDS;

EID: 84925617561     PISSN: 16878760     EISSN: 16878779     Source Type: Journal    
DOI: 10.1155/2015/164974     Document Type: Review

References (71)

1. K. Wilke, A. Martin, L. Terstegen, and S. S. Biel, "A short history of sweat gland biology," International Journal ofCosmetic Science, vol. 29, no. 3, pp. 169-179, 2007.
2. K. Sato, W. H. Kang, K. Saga, and K. T. Sato, "Biology of sweat glands and their disorders. I. Normal sweat gland function," Journal of the American Academy of Dermatology, vol. 20, no. 4, pp. 537-563, 1989.
3. Y. H. Caplan and B. A. Goldberger, "Alternative specimens for workplace drug testing," Journal ofAnalytical Toxicology, vol. 25, no. 5, pp. 396-399, 2001.
4. R. de la Torre, M. Farré, M. Navarro, R. Pacifici, P. Zuccaro, and S. Pichini, "Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and nonconventional matrices," Clinical Pharmacokinetics, vol. 43, no. 3, pp. 157-185, 2004.
5. S. Pichini, I. Altieri, P. Zuccaro, and R. Pacifici, "Drug monitoring in non-conventional biologic fluids and matrices," Clinical Pharmacokinetics, vol. 30, no. 3, pp. 211-228, 1996.
6. M. M. Raiszadeh, M. M. Ross, P. S. Russo et al., "Proteomic analysis of eccrine sweat: implications for the discovery of schizophrenia biomarker proteins," Journal of Proteome Research, vol. 11, no. 4, pp. 2127-2139, 2012.
7. P. Kintz, A. Tracqui, P. Mangin, and Y. Edel, "Sweat testing in opioid users with a sweat patch," Journal of Analytical Toxicology, vol. 20, no. 6, pp. 393-397, 1996.
8. B. R. Brunet, A. J. Barnes, K. B. Scheidweiler, P. Mura, and M.A. Huestis, "Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification ofmethadone, heroin, cocaine and metabolites in sweat," Analytical and Bioanalytical Chemistry, vol. 392, no. 1-2, pp. 115-127, 2008.
9. E. Gallardo and J. A. Queiroz, "The role of alternative specimens in toxicological analysis," Biomedical Chromatography, vol. 22, no. 8, pp. 795-821, 2008.
10. M. A. Huestis, E. J. Cone, C. J. Wong, A. Umbricht, and K. L. Preston, "Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing," Journal of Analytical Toxicology, vol. 24, no. 7, pp. 509-521, 2000.
11. A. Mena-Bravo and M. D. Luque de Castro, "Sweat: a sample with limited present applications and promising future in metabolomics," Journal of Pharmaceutical and Biomedical Analysis, vol. 90, pp. 139-147, 2014.
12. M. A. Huestis, K. B. Scheidweiler, T. Saito et al., "Excretion of Δ 9-tetrahydrocannabinol in sweat," Forensic Science International, vol. 174, no. 2-3, pp. 173-177, 2008.
13. B. R. Brunet, A. J. Barnes, R. E. Choo, P. Mura, H. E. Jones, and M. A. Huestis, "Monitoring pregnant women's illicit opiate and cocaine use with sweat testing," Therapeutic Drug Monitoring, vol. 32, no. 1, pp. 40-49, 2010.
14. N. Fucci and N. de Giovanni, "Methadone in hair and sweat from patients in long-term maintenance therapy," Therapeutic Drug Monitoring, vol. 29, no. 4, pp. 452-454, 2007.
15. N. Fucci, N. De Giovanni, and S. Scarlata, "Sweat testing in addicts under methadone treatment: an Italian experience," Forensic Science International, vol. 174, no.2-3, pp. 107-110, 2008.
16. E. W. Schwilke, A. J. Barnes, S. L. Kacinko, E. J. Cone, E. T. Moolchan, and M. A. Huestis, "Opioid disposition in human sweat after controlled oral codeine administration," Clinical Chemistry, vol. 52, no. 8, pp. 1539-1545, 2006.
17. D. A. Kidwell and F. P. Smith, "Susceptibility of PharmChek drugs of abuse patch to environmental contamination," Forensic Science International, vol. 116, no. 2-3, pp. 89-106, 2001.
18. M. A. Huestis, J. M. Oyler, E. J. Cone, A. T. Wstadik, D. Schoendorfer, and R. E. Joseph Jr., "Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry," Journal of Chromatography B: Biomedical Sciences and Applications, vol. 733, no. 1-2, pp. 247-264, 1999.
19. S. Schneider, Z. Ait-m-bark, C. Schummer et al., "Determination of fentanyl in sweat and hair of a patient using transdermal patches," Journal of Analytical Toxicology, vol. 32, no. 3, pp. 260-264, 2008.
20. S. J. Genuis, D. Birkholz, I. Rodushkin, and S. Beesoon, "Blood, urine, and sweat (BUS) study: monitoring and elimination of bioaccumulated toxic elements," Archives of Environmental Contamination and Toxicology, vol. 61, no. 2, pp. 344-357, 2011.
21. J. W. Robinson and E. M. Skelly, "The direct determination of mercury in sweat," Spectroscopy Letters, vol. 16, no. 2, pp. 133-150, 1983.
22. F. W. Sunderman, "Clinical response to therapeutic agents in poisoning from mercury vapor," Annals of Clinical and Laboratory Science, vol. 8, no. 4, pp. 259-269, 1978.
23. H. B. Lovejoy, Z. G. Bell Jr., and T. R. Vizena, "Mercury exposure evaluations and their correlation with urine mercury excretions. 4. Elimination of mercury by sweating," Journal of Occupational Medicine, vol. 15, no. 7, pp. 590-591, 1973.
24. J. L. Stauber and T. M. Florence, "Acomparative study of copper, lead, cadmium and zinc in human sweat and blood," Science of the Total Environment, vol. 74, pp. 235-247, 1988.
25. J. L. Stauber and T. M. Florence, "The determination of trace metals in sweat by anodic stripping voltammetry," Science of the Total Environment, vol. 60, pp. 263-271, 1987.
26. J.W. Robinson and S. Weiss, "The direct determination of cadmiumin hair using carbon bed atomic absorption spectroscopy. Daily rate of loss of cadmium in hair, urine and sweat," Journal of Environmental Science and Health, Part A Environmental Science and Engineering, vol. 15, no. 6, pp. 663-697, 1980.
27. J. R. Cohn and E. A. Emmett, "The excretion of trace metals in human sweat," Annals of Clinical and Laboratory Science, vol. 8, no. 4, pp. 270-275, 1978.
28. F. O. Omokhodion and J. M. Howard, "Trace elements in the sweat of acclimatized persons," Clinica Chimica Acta, vol. 231, no. 1, pp. 23-28, 1994.
29. A. K. M. Yousuf, M. Misbahuddin, and M. S. Rahman, "Secretion of arsenic, cholesterol, vitamin E, and zinc from the site of arsenical melanosis and leucomelanosis in skin," Clinical Toxicology, vol. 49, no. 5, pp. 374-378, 2011.
30. S.G. Lilley, T.M. Florence, and J. L. Stauber, "Theuse of sweat to monitor lead absorption through the skin," Science of the Total Environment, vol. 76, no. 2-3, pp. 267-278, 1988.
31. F. O. Omokhodion and G. W. Crockford, "Sweat lead levels in persons with high blood lead levels: experimental elevation of blood lead by ingestion of lead chloride," Science of the Total Environment, vol. 108, no. 3, pp. 235-242, 1991.
32. F. O. Omokhodion and G. W. Crockford, "Lead in sweat and its relationship to salivary and urinary levels in normal healthy subjects," Science of the Total Environment, vol. 103, no. 2-3, pp. 113-122, 1991.
33. D. C. Hohnadel, F. W. Sunderman Jr., M. W. Nechay, and M. D. McNeely, "Atomic absorption spectrometry of nickel, copper, zinc, and lead in sweat collected from healthy subjects during sauna bathing," Clinical Chemistry, vol. 19, no. 11, pp. 1288-1292, 1973.
34. F. O. Omokhodion and J. M. Howard, "Sweat lead levels in persons with high blood lead levels: lead in sweat of lead workers in the tropics," Science of the Total Environment, vol. 103, no. 2-3, pp. 123-128, 1991.
35. I. A. ParpaleѤ, L. G. Prokof 'eva, and V. G. Obertas, "The use of the sauna for disease prevention in the workers of enterprises with chemical and physical occupational hazards," Vracebnoe delo Kiev, no. 5, pp. 93-95, 1991.
36. P. Haber, F. Ring, O. Jahn, and V. Meisinger, "Influence of intensive and extensive aerobic circulatory stress on blood lead levels," Zentralblatt fur Arbeitsmedizin, Arbeitsschutz, Prophylaxe und Ergonomie, vol. 35, no. 10, pp. 303-306, 1985 (German).
37. M. Barroso, E. Gallardo, D. N. Vieira, J. A. Queiroz, and M. López-Rivadulla, "Bioanalytical procedures and recent developments in the determination of opiates/opioids in human biological samples," Analytical and Bioanalytical Chemistry, vol. 400, no. 6, pp. 1665-1690, 2011.
38. P. Kintz and N. Samy, "Unconventional samples and alternative matrices," in Handbook of Analytical Separations, M. J. Bogusz, Ed., vol. 2, pp. 459-488, Elsevier Science, Amsterdam, The Netherlands, 2000.
39. B. M. R. Appenzeller, C. Schummer, S. B. Rodrigues, and R. Wennig, "Determination of the volume of sweat accumulated in a sweat-patch using sodium and potassium as internal reference," Journal of Chromatography B, vol. 852, no. 1-2, pp. 333-337, 2007.
40. V. P. Kutyshenko, M. Molchanov, P. Beskaravayny, V. N. Uversky, and M. A. Timchenko, "Analyzing and mapping sweat metabolomics by high-resolution NMR spectroscopy," PLoS ONE, vol. 6, no. 12, Article IDe28824, 2011.
41. S. M. Rowe, F. Accurso, and J. P. Clancy, "Detection of cystic fibrosis transmembrane conductance regulator activity in earlyphase clinical trials," Proceedings of the American Thoracic Society, vol. 4, no. 4, pp. 387-398, 2007.
42. M. R. Ely, B. R. Ely, T. D. Chinevere, C. P. Lacher, H. C. Lukaski, and S. N. Cheuvront, "Evaluation of the Megaduct sweat collector for mineral analysis," Physiological Measurement, vol. 33, no. 3, pp. 385-394, 2012.
43. V. Oncescu, D. O'Dell, and D. Erickson, "Smartphone based health accessory for colorimetric detection of biomarkers in sweat and saliva," Lab on a Chip, vol. 13, no. 16, pp. 3232-3238, 2013.
44. C. Staub, "Chromatographic procedures for determination of cannabinoids in biological samples, with special attention to blood and alternative matrices like hair, saliva, sweat and meconium," Journal of Chromatography B: Biomedical Sciences and Applications, vol. 733, no. 1-2, pp. 119-126, 1999.
45. S. Pichini, Distribution of 3,4-methylenedioxymethamphetamine (MDMA) in non conventional matrices and its applications in clinical toxicology [Thesis], Autonomous University of Barcelona, 2005.
46. N. Uemura, R. P. Nath, M. R. Harkey, G. L. Henderson, J. Mendelson, and R. T. Jones, "Cocaine levels in sweat collection patches vary by location of patch placement and decline over time," Journal of Analytical Toxicology, vol. 28, no. 4, pp. 253-259, 2004.
47. E. Gallardo, M. Barroso, and J. A. Queiroz, "LC-MS: a powerful tool in workplace drug testing," Drug Testing and Analysis, vol. 1, no. 3, pp. 109-115, 2009.
48. J. Segura, R. Ventura, and C. Jurado, "Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents," Journal of Chromatography B: Biomedical Applications, vol. 713, no. 1, pp. 61-90, 1998.
49. V. A. Legrys, "Sweat testing for the diagnosis of cystic fibrosis: practical considerations," Journal of Pediatrics, vol. 129, no.6, pp. 892-897, 1996.
50. K. T. Myint, K. Aoshima, S. Tanaka, T. Nakamura, and Y. Oda, "Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry," Analytical Chemistry, vol. 81, no. 3, pp. 1121-1129, 2009.
51. M. I. Barrio Gómez De Agüero, G. García Hernández, S. Gartner et al., "Protocol for the diagnosis and follow up of patients with cystic fibrosis," Anales de Pediatria, vol. 71, no. 3, pp. 250-264, 2009.
52. M. Beauchamp and L. C. Lands, "Sweat-testing: a review of current technical requirements," Pediatric Pulmonology, vol. 39, no. 6, pp. 507-511, 2005.
53. M. M. Reddy and P. M. Quinton, "Cytosolic potassiumcontrols CFTR deactivation in human sweat duct,"TheAmerican Journal of Physiology - Cell Physiology, vol. 291, no. 1, pp. C122-C129, 2006.
54. J. Moyer, D. Wilson, I. Finkelshtein, B. Wong, and R. Potts, "Correlation between sweat glucose and blood glucose in subjects with diabetes," Diabetes Technology and Therapeutics, vol. 14, no. 5, pp. 398-402, 2012.
55. N. Papanas, A. J. M. Boulton, R. A. Malik et al., "A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy," DiabeticMedicine, vol. 30, no. 5, pp. 525-534, 2013.
56. V. Sikirzhytski, A. Sikirzhytskaya, and I. K. Lednev, "Multidimensional Raman spectroscopic signature of sweat and its potential application to forensic body fluid identification," Analytica Chimica Acta, vol. 718, pp. 78-83, 2012.
57. B. Jurado Gámez, A. Salvatierra Velázquez, M. Calderón Santiago, F. Priego Capote, and M. D. Luque de Castro, "Patent Método de clasificación, diagnóstico y seguimiento de individuos con riesgo de padecer cáncer de pulmónmediante el análisis de sudor," P201331228, 13/P/S049, August 2013.
58. D. Porter, S. Weremowicz, K. Chin et al., "A neural survival factor is a candidate oncogene in breast cancer," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 19, pp. 10931-10936, 2003.
59. M. I. Hassan, A. Waheed, S. Yadav, T. P. Singh, and F. Ahmad, "Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications," Cellular and Molecular Life Sciences, vol. 66, no. 3, pp. 447-459, 2009.
60. T. Colpitts, E. L. Russell, S. Frost, J. Ramirez, B. Singh, and J. C. Russell, "Patent: method and marker combinations for screening for predisposition to lung cancer," Pub. No. US 2012/0071334 A1, 2012.
61. S. Pichini, M. Navarro, R. Pacifici et al., "Usefulness of sweat testing for the detection of MDMA after a single-dose administration," Journal of Analytical Toxicology, vol. 27, no. 5, pp. 294-303, 2003.
62. N. Samyn, G. de Boeck, and A. G. Verstraete, "The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers," Journal of Forensic Sciences, vol. 47, no. 6, pp. 1380-1387, 2002.
63. R. de la Torre and S. Pichini, "Usefulness of sweat testing for the detection of cannabis smoke," Clinical Chemistry, vol. 50, no. 11, pp. 1961-1962, 2004.
64. J. Lozano, O. García-Algar, O. Vall, R. De La Torre, G. Scaravelli, and S. Pichini, "Biological matrices for the evaluation of in utero exposure to drugs of abuse," Therapeutic Drug Monitoring, vol. 29, no. 6, pp. 711-734, 2007.
65. N. Samyn and C. van Haeren, "On-site testing of saliva and sweat with drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users," International Journal of Legal Medicine, vol. 113, no. 3, pp. 150-154, 2000.
66. P. Bhattacharjee, D. Chatterjee, K. K. Singh, and A. K. Giri, "Systems biology approaches to evaluate arsenic toxicity and carcinogenicity: an overview," International Journal of Hygiene and Environmental Health, vol. 216, no. 5, pp. 574-586, 2013.
67. B. Buszewski, T. Ligor, J. Rudnicka, T. Jezierski, M. Walczak, and A. Wenda-Piesik, "Analysis of cancer biomarkers in exhaled breath and comparison with sensory indications by dog," in Volatile Biomarkers: Non-Invasive Diagnosis in Physiology and Medicine, A. Amann and D. Smith, Eds., pp. 177-192, Elsevier, Amsterdam, The Netherlands, 2013.
68. P. Wallace, "Individual discrimination of humans by odor," Physiology & Behavior, vol. 19, no. 4, pp. 577-579, 1977.
69. S. Kuukasjärvi, C. J. P. Eriksson, E. Koskela, T. Mappes, K. Nissinen, and M. J. Rantala, "Attractiveness of women's body odors over the menstrual cycle: the role of oral contraceptives and receiver sex," Behavioral Ecology, vol. 15, no. 4, pp. 579-584, 2004.
70. M. Gallagher, C. J. Wysocki, J. J. Leyden, A. I. Spielman, X. Sun, and G. Preti, "Analyses of volatile organic compounds from human skin," British Journal of Dermatology, vol. 159, no. 4, pp. 780-791, 2008.
71. F. Kuhn and A. Natsch, "Body odour of monozygotic human twins: a common pattern of odorant carboxylic acids released by a bacterial aminoacylase from axilla secretions contributing to an inherited body odour type," Journal of the Royal Society Interface, vol. 6, no. 33, pp. 377-392, 2009.